-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Achilles Therapeutics plc quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q2 2024.
- Achilles Therapeutics plc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $8K.
- Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2023 was $491K, a 342% increase from 2022.
- Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2022 was $111K, a 200% increase from 2021.
- Achilles Therapeutics plc annual Income Tax Expense (Benefit) for 2021 was $37K, a 1133% increase from 2020.
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)